transfusion-dependent anemia


Also found in: Dictionary, Thesaurus, Encyclopedia.

transfusion-dependent anemia

Anemia for which the only effective therapy is repeated blood transfusions.

CAUTION!

Iron overload may be a complication of therapy, esp. after the transfusion of over 10 units of blood.
See also: anemia
References in periodicals archive ?
REVLIMID([R]) (lenalidomide) is indicated for patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
This agent was granted restricted distribution for transfusion-dependent anemia due to low or intermediate MDS associated with deletion 5q cytogenetic abnormalities.

Full browser ?